Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$30.19 - $40.28 $531,344 - $708,928
-17,600 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$29.09 - $45.68 $511,984 - $803,968
17,600 New
17,600 $39,000
Q1 2021

May 14, 2021

SELL
$33.61 - $49.95 $810,001 - $1.2 Million
-24,100 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$26.52 - $49.35 $639,132 - $1.19 Million
24,100 New
24,100 $76,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $349M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.